Shuimu Molecule, a Tsinghua AIR spinout, builds conversational AI drug design platform ChatDD
AIShuimu Molecule, a three-year-old AI drug company incubated by Tsinghua AIR, is the only AI pharmaceutical firm on CCTV's "Ten Steeds of China's AI Startups" list. The company's ChatDD platform lets drug researchers direct AI agents through natural-language dialogue, and it says a self-developed autoimmune bispecific antibody project reached preclinical candidate in seven months, versus 12–24 months with traditional methods.
Source details
QbitAI · 鹭羽 · qbitai.comPublished · added here
Original title: 央视严选「中国AI创业十骏」：唯一AI制药公司是清华系